Related Content
September 18, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...
September 18, 2023
December 22, 2022 — Johnson & Johnson today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now ...
December 22, 2022
November 1, 2022 — Johnson & Johnson and Abiomed, a world leader in breakthrough heart, lung and kidney support ...
November 01, 2022
May 2, 2022 – Johnson & Johnson MedTech have announced that Biosense Webster, Inc., a worldwide leader in the science ...
May 02, 2022
CERENOVUS Launches EMBOGUARD Balloon Guide Catheter to Use In the Treatment of Acute Ischemic Stroke
February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...
February 15, 2022
Feature | Coronavirus (COVID-19)| By Dave Fornell, Editor
(This story was updated May 7, 2021 in the last subheaded section) April 13, 2021 — The U.S. Food and Drug ...
April 13, 2021
December 7, 2018 — New data from the Phase 3 CASSINI study showed a 60 percent reduction of venous thromboembolism (VTE ...
December 07, 2018
March 15, 2018 – Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who works in ...
March 15, 2018
January 5, 2017 — A new report published by Allied Market Research forecasts that the global thrombectomy devices market ...
January 05, 2017March 9, 2015 — Boston Scientific Corp. announced the settlement of the breach of merger agreement lawsuit brought by ...
March 09, 2015